Table 1.
Clinical and demographic characteristics of patients with schizophrenia and healthy control participants.
| Schizophrenia patients Mean (SD) |
Healthy controls Mean (SD) |
Stat. val. | p-value | |
|---|---|---|---|---|
| Age (years) | 33.92 (7.27) | 36.51 (7.23) | t = 0.46 | 0.46 |
| Sex (male/female) | 15/8 | 12/11 | χ2 = 0.81 | 0.37 |
| Edinburgh Handedness Quotient | 85.87 (33.05) | 85 (32.79) | t = -0.09 | 0.93 |
| Education (years) | 12.70 (2.01) | 13.13 (1.79) | t = 0.77 | 0.44 |
| Duration of illness (years) | 12.43 (6.50) | |||
| PANSS (overall score) | 66.30 (18.58) | |||
| PANSS (positive subscale) | 10.91 (3.54) | |||
| PANSS (negative subscale) | 23.52 (9.11) | |||
| PANSS (general psychopathology) | 31.86 (8.64) | |||
| SANS score | 46.09 (25.37) | |||
| Neuroleptic dosage (CPZ equivalent) | 680.39 (461.56) | |||
| Patients on antidepressants (%) | 26.09% |
Stat. val., statistical values; PANSS, Positive and Negative Syndrome Scale; SANS, Scale for the Assessment of Negative Symptoms; CPZ, chlorpromazine; t, t-test for two independent groups.